Healthcare Scientists Knowledge Transfer Partnership (HCS KTP)

We advanced the standardisation of emerging genomic technologies within the UK healthcare system by supporting efforts to coordinate quality control, benchmarking and knowledge‑sharing across UK Genomic Laboratory Hubs. Through workshops and inter‑laboratory study coordination, we helped address challenges in implementing new testing approaches—such as liquid biopsies—into routine clinical services. This work strengthens the reliability and comparability of genomic testing nationwide and supports the effective translation of technological advances into patient care.

We strengthened the accuracy and comparability of measurable residual disease (MRD) testing for acute myeloid leukaemia by supporting national efforts to standardise molecular approaches across clinical laboratories. By working with clinicians and scientists, molecular test and quality material manufactures to identify priorities and propose standardisation pathways, we helped shape recommendations for the development of WHO International Standard reference materials for frequently tested AML biomarkers. This work embeds measurement traceability within EQA scheme, supporting better relationships between measurement science and healthcare providers, and ultimately contributes to better clinical decision‑making and patient outcomes.